Insider Transactions in Q1 2025 at Centessa Pharmaceuticals PLC (CNTA)
Insider Transaction List (Q1 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 25
2025
|
Gregory M Weinhoff Chief Business Officer |
SELL
Open market or private sale
|
Direct |
11,494
-7.9%
|
$172,410
$15.25 P/Share
|
Feb 20
2025
|
Saurabh Saha Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
55,000
-7.14%
|
$880,000
$16.23 P/Share
|
Feb 18
2025
|
Iqbal J Hussain General Counsel |
SELL
Open market or private sale
|
Direct |
6,000
-2.72%
|
$96,000
$16.48 P/Share
|
Feb 18
2025
|
Iqbal J Hussain General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+5.11%
|
$30,000
$5.84 P/Share
|
Feb 10
2025
|
Karen M. Anderson Chief People Officer |
SELL
Open market or private sale
|
Direct |
429
-0.78%
|
$7,722
$18.99 P/Share
|
Feb 10
2025
|
Karen M. Anderson Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
429
+0.78%
|
$1,716
$4.01 P/Share
|
Feb 07
2025
|
Karen M. Anderson Chief People Officer |
SELL
Open market or private sale
|
Direct |
30,526
-35.98%
|
$579,994
$19.03 P/Share
|
Feb 07
2025
|
Karen M. Anderson Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,526
+26.46%
|
$122,104
$4.01 P/Share
|
Feb 03
2025
|
Tia L Bush Chief Technology & Quality Ofc |
SELL
Open market or private sale
|
Direct |
11,000
-8.3%
|
$176,000
$16.86 P/Share
|
Feb 03
2025
|
Karen M. Anderson Chief People Officer |
SELL
Open market or private sale
|
Direct |
6,471
-10.64%
|
$103,536
$16.86 P/Share
|
Feb 01
2025
|
David M Chao Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,324
-5.51%
|
$213,184
$16.92 P/Share
|
Feb 01
2025
|
Tia L Bush Chief Technology & Quality Ofc |
SELL
Payment of exercise price or tax liability
|
Direct |
8,693
-6.16%
|
$139,088
$16.92 P/Share
|
Feb 01
2025
|
Gregory M Weinhoff Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,267
-8.93%
|
$228,272
$16.92 P/Share
|
Feb 01
2025
|
Iqbal J Hussain General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
12,879
-10.89%
|
$206,064
$16.92 P/Share
|
Feb 01
2025
|
Karen M. Anderson Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,732
-15.0%
|
$171,712
$16.92 P/Share
|
Feb 01
2025
|
Saurabh Saha Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
43,381
-10.1%
|
$694,096
$16.92 P/Share
|
Jan 27
2025
|
Gregory M Weinhoff Chief Business Officer |
SELL
Open market or private sale
|
Direct |
11,742
-6.85%
|
$187,872
$16.47 P/Share
|
Jan 21
2025
|
Saurabh Saha Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
55,000
-5.7%
|
$825,000
$15.98 P/Share
|
Jan 15
2025
|
Iqbal J Hussain General Counsel |
SELL
Open market or private sale
|
Direct |
6,000
-4.83%
|
$90,000
$15.29 P/Share
|
Jan 15
2025
|
Iqbal J Hussain General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+4.61%
|
$30,000
$5.84 P/Share
|